Fondazione Policlinico A.Gemelli IRCCS
Roma, 00168, Italy
NCT Number: NCT06357052
Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, ranging from pure steatosis to non-alcoholic steatohepatitis and ultimately to liver cirrhosis. In order to study the association between NAFLD and nephrolithiasis while minimizing the confounding effect of metabolic syndrome, we investigated the impact of different degrees of NAFLD severity on potential risk factors for stone formation.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Roma, 00168, Italy
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 15 years
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
Acronym: LINA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04248335
Body Weight, Deglutition Disorders
Kansas City, Missouri, United States
View Trial DetailsNCT05370053
Digestive System Diseases, Fatty Liver
Kansas City, Kansas, United States
View Trial DetailsNCT06697977
Body Weight, Diabetes
Amman, Jordan
View Trial DetailsNCT06410924
Digestive System Diseases, Fatty Liver
Maitland, Florida, United States
View Trial Details